New drug trial aims to tame sarcoidosis and cut steroid dependence
Disease control
Recruiting now
This study is testing a new drug called XTMAB-16 for adults with pulmonary sarcoidosis, a disease that causes inflammation and scarring in the lungs. The main goals are to see if the drug is safe and if it can help patients reduce their daily dose of steroid medications, which of…
Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC